• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    396.61 Down 15.98(3.87%) 4:00PM EST
    |After Hours : 396.61 0.00 (0.00%) 5:19PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 1,137,422   998,617   869,612   802,329  
    Cost of Revenue109,083  88,840  83,955  59,474  
    Gross Profit 1,028,339   909,777   785,657   742,855  
    Operating Expenses
    Research Development425,924  390,330  343,113  351,745  
    Selling General and Administrative209,993  174,588  158,991  160,795  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 392,422   344,859   283,553   230,315  
    Income from Continuing Operations
    Total Other Income/Expenses Net2,582  (14,115)(861)(19,730)
    Earnings Before Interest And Taxes395,004  330,744  282,692  210,585  
    Interest Expense1,715  2,748  6,169  6,350  
    Income Before Tax393,289  327,996  276,523  204,235  
    Income Tax Expense182,891  133,353  200,502  104,192  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops210,377  178,679  75,079  77,361  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 210,398   194,643   76,021   100,043  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 210,398   194,643   76,021   100,043  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.